医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Jinchi Biotech Ltd Held 2014 Semi-Annual Marketing Conference

2014年08月12日 PM04:00
このエントリーをはてなブックマークに追加


 

ZHANGJIAJIE, China

Jinchi Biotech Ltd. (JBL) 2014 Semi–Annual Marketing Conference was held in Changsha Headquarter on July 28, 2014, attended by Mr. Haibo Zhang – Chairman, Mr. Jing Cai – CEO, Ms. Shujun Zhou – CFO, and all the relevant departments heads, to discuss JBL’s marketing strategies and plans for the second half of 2014.

In the second half of 2014, JBL is going to strengthen its position in the specialized cosmetic market. Given that JBL has already developed mature distribution channels within the specialized cosmetic market, with great growth potential, JBL is going to invite all SHINIQUE VIP customers from all over China to attend the ’3rd SHINIQUE Health Journey’, held from Aug 21, 2014 to Aug 24, 2014, to discuss cooperation opportunities. In 2014, JBL plans to achieve RMB 6 million sales in specialized cosmetic market.

According to China’s Ministry of Commerce, during the first half year of 2014, the total revenue of China’s E-commerce is around RMB 5.66 Trillion, representing a 30.1% increase compared to last year. In this case, JBL will focus on building an integrated E-commerce system as its key competitive advantage, with two brands, ‘SHINIQUE’ and ‘ANDRIAS’ and two well-known E-commerce platforms, ‘www.tmall.com‘ and ‘www.jd.com‘, as well as independent B2C platform and online social platforms.

JBL has recruited over 20 talents in the E-commerce field for its operation team till now and aims to expand to more than 100 by the end of this year. Up to the end of July 2014, JBL has finished products design and development, TMALL online store application, products production and quality inspection for ‘ANDRIAS’ brand, with TMALL store design, and development of ‘WECHAT’ and ‘WEIBO’ online social platforms expected to be finished by August 20th. JBL plans to open its ‘ANDRIAS’ TMALL online store on Sep. 1st, 2014.

JBL is aiming to take a leading position in China’s bio-tech cosmetic market, with its exclusive patent ingredients, strong R&D capacities, significant anti-aging results and developed marketing model.

ABOUT JINCHI

www.jc-biotech.com

Owning the world’s only Giant Salamander Museum, Jinchi Biotech Ltd. mainly specialized in the R&D of giant salamander related biotech products with more than 40 skincare and health products under two product lines, namely SHINIQUE and ANDRIAS. With strong scientific research background and a comprehensive business model, Jinchi Biotech Ltd. values virtue and goodwill, commits to deliver quality products to consumers, and devotes to the health, beauty and biomedical industries.

Disclaimer

The statements contained herein are forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in the forward-looking statements.

CONTACT

Jinchi Biotech Ltd.
Chan Luo, +86-731-8979-2661
ir@jc-biotech.com

同じカテゴリーの記事 

  • Avistone Announces the Approval of Vebreltinib as the First MET-TKI Treatment for a Rare Brain Glioma Subtype in China
  • Inocras Pioneers Precision Health with Revolutionary Whole Genome Insights
  • エクセルゲン、バクスター・インターナショナルを提訴。口腔体温計の精度に関するデータの公表権を擁護
  • パース・バイオサイエンシズが研究室用自動化プロバイダー・プログラムをローンチし、ハミルトン、オープントロンズ、ラボワークス、SPTラボテックと提携
  • Parse Biosciences与Hamilton、Opentrons Labworks和SPT Labtech合作推出实验室自动化供应商计划